SHH and hepatocellular carcinoma: Another mechanism of resistance to sorafenib was associated with the sonic hedgehog (SHH) pathway; when added to patient-derived HCC organoids, the SHH inhibitor GANT61 and sorafenib improved antitumor response [65].